TY - JOUR
T1 - Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period
T2 - A Single-Center Retrospective Study
AU - Tanaka, Yasuhiro
AU - Yamamoto, Kazuko
AU - Morimoto, Shimpei
AU - Nabeshima, Takeshi
AU - Matsushima, Kayoko
AU - Ishimoto, Hiroshi
AU - Ashizawa, Nobuyuki
AU - Hirayama, Tatsuro
AU - Takeda, Kazuaki
AU - Gyotoku, Hiroshi
AU - Iwanaga, Naoki
AU - Takemoto, Shinnosuke
AU - Fukahori, Susumu
AU - Takazono, Takahiro
AU - Yamaguchi, Hiroyuki
AU - Kido, Takashi
AU - Sakamoto, Noriho
AU - Hosogaya, Naoki
AU - Akabame, Shogo
AU - Sugimoto, Takashi
AU - Yamanashi, Hirotomo
AU - Matsui, Kosuke
AU - Izumida, Mai
AU - Fujita, Ayumi
AU - Tashiro, Masato
AU - Tanaka, Takeshi
AU - Ariyoshi, Koya
AU - Furumoto, Akitsugu
AU - Morita, Kouichi
AU - Izumikawa, Koichi
AU - Yanagihara, Katsunori
AU - Mukae, Hiroshi
N1 - Funding Information:
This research was supported by AMED under grant number JP21jm0210087h0002 to K.Y.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/9
Y1 - 2022/9
N2 - Managing mild illness in COVID-19 and predicting progression to severe disease are concerning issues. Here, we investigated the outcomes of Japanese patients with mild COVID-19, and identified triage risk factors for further hospitalization and emergency department (ED) visits at a single tertiary hospital. A triage checklist with 30 factors was used. Patients recommended for isolation were followed up for 10 days for subsequent ED visits or hospital admission. Overall, 338 patients (median age, 44.0; 45% women) visited the clinic 5.0 days (median) after symptom onset. Thirty-six patients were immediately hospitalized following triage; others were isolated. In total, 72 non-hospitalized patients visited the ED during their isolation, and 30 were hospitalized after evaluation for oxygen desaturation. The median ED visit and hospitalization durations after symptom onset were 5.0 and 8.0 days, respectively. The checklist factors associated with hospitalization during isolation were age > 50 years, body mass index > 25 kg/m2, hypertension, tachycardia with pulse rate > 100/min or blood pressure > 135 mmHg at triage, and >3-day delay in hospital visit after symptom onset. No patients died. Altogether, 80% of patients with mild COVID-19 could be safely isolated at home. Age, BMI, underlying hypertension, date after symptom onset, tachycardia, and systolic blood pressure at triage might be related to later hospitalization.
AB - Managing mild illness in COVID-19 and predicting progression to severe disease are concerning issues. Here, we investigated the outcomes of Japanese patients with mild COVID-19, and identified triage risk factors for further hospitalization and emergency department (ED) visits at a single tertiary hospital. A triage checklist with 30 factors was used. Patients recommended for isolation were followed up for 10 days for subsequent ED visits or hospital admission. Overall, 338 patients (median age, 44.0; 45% women) visited the clinic 5.0 days (median) after symptom onset. Thirty-six patients were immediately hospitalized following triage; others were isolated. In total, 72 non-hospitalized patients visited the ED during their isolation, and 30 were hospitalized after evaluation for oxygen desaturation. The median ED visit and hospitalization durations after symptom onset were 5.0 and 8.0 days, respectively. The checklist factors associated with hospitalization during isolation were age > 50 years, body mass index > 25 kg/m2, hypertension, tachycardia with pulse rate > 100/min or blood pressure > 135 mmHg at triage, and >3-day delay in hospital visit after symptom onset. No patients died. Altogether, 80% of patients with mild COVID-19 could be safely isolated at home. Age, BMI, underlying hypertension, date after symptom onset, tachycardia, and systolic blood pressure at triage might be related to later hospitalization.
UR - http://www.scopus.com/inward/record.url?scp=85138605762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138605762&partnerID=8YFLogxK
U2 - 10.3390/jcm11185444
DO - 10.3390/jcm11185444
M3 - Article
AN - SCOPUS:85138605762
VL - 11
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
SN - 2077-0383
IS - 18
M1 - 5444
ER -